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RAS genes are among the most frequently mutated
proto-oncogenes in cancer. However, how Ras sta-
bility is regulated remains largely unknown. Here,
we report a regulatory loop involving the E3 ligase
Nedd4-1, Ras, and PTEN. We found that Ras
signaling stimulates the expression of Nedd4-1,
which in turn acts as an E3 ubiquitin ligase that regu-
lates Ras levels. Importantly, Ras activation, either
by oncogenic mutations or by epidermal growth fac-
tor (EGF) signaling, prevents Nedd4-1-mediated Ras
ubiquitination. This leads to Ras-induced Nedd4-1
overexpression, and subsequent degradation of the
tumor suppressor PTEN in both human cancer sam-
ples and cancer cells. Our study thus unravels the
molecular mechanisms underlying the interplay of
Ras, Nedd4-1, and PTEN and suggests a basis for
the high prevalence of Ras-activating mutations
and EGF hypersignaling in cancer.INTRODUCTION
Ras proteins (K-Ras, H-Ras, and N-Ras) are small guanosine tri-
phosphatases (GTPases) that act as key molecular switches in
regulating a wide range of cellular processes, especially in con-
trolling cell proliferation, transformation, differentiation, and sur-
vival (Ahearn et al., 2012; Malumbres and Barbacid, 2003). Their
activities are tightly controlled by cycling between active guano-
sine triphosphate (GTP)-bound and inactive guanosine diphos-
phate (GDP)-bound states (Ahearn et al., 2012). Serving as a
signaling hub, Ras proteins are activated by guanine nucleotide
exchange factors (GEFs) in response to upstream signaling from
binding of various growth factors such as epidermal growth fac-
tor (EGF) to their tyrosine kinase receptors, triggering diverse
downstream signal cascades (Ahearn et al., 2012; Downward,
2003). The activated GTP-bound form of Ras proteins is con-
verted to the GDP-bound form by their GTPase-activating pro-
teins (GAPs).Mutations in Ras that predominantly occur at G12, G13, and
Q61 result in a persistent GTP-bound state of Ras due to a defect
in hydrolysis of GTP to GDP, leading to a constitutive activation
of downstream signaling (Buhrman et al., 2010; Scheffzek et al.,
1997; Scheidig et al., 1999). Ras mutations are found in about
30% of all human cancers, and up to 90% in pancreas cancer
and 50% in colorectal or thyroid cancer, establishing RAS genes
as themost prominent proto-oncogenes (Bos, 1989; Downward,
2003; Pylayeva-Gupta et al., 2011). In addition to the oncogenic
activation by point mutations, Ras signaling can also be aber-
rantly activated by epidermal growth factor receptor (EGFR)
overexpression or mutations, or increased production of auto-
crine EGF-like factors in tumors (Downward, 2003). For the
past 4 decades, intensive efforts have been made to determine
the underlying mechanism for regulation of Ras activity and
Ras-induced tumorigenesis.
The Nedd4 (neural precursor cell expressed developmentally
downregulated protein 4) family ubiquitin ligases belong to the
homologous to the E6-AP carboxyl terminus type of E3s and
play important roles in tumor progression by affecting various
tumorigenesis-related signaling pathways, including transform-
ing growth factor b, EGF, vascular endothelial growth factor
(VEGF), insulin-like growth factor (IGF), and tumor necrosis fac-
tor a (Chen and Matesic, 2007; Rotin and Kumar, 2009).
Nedd4-1 is the founding member of this family. It was originally
identified as an E3 ligase for the epithelial sodium channel
(ENaC) that regulates ENaC endocytosis and stability (Staub
et al., 1996, 2000). Further studies showed that Nedd4-1 could
target other different substrates including insulin-like growth fac-
tor 1 receptor (IGF1R), vascular endothelial growth factor recep-
tor 2 (VEGF-R2), and phosphatase and tensin homolog (PTEN)
for degradation (Chen and Matesic, 2007; Rotin and Kumar,
2009), suggesting that Nedd4-1 may play distinct roles in the
regulation of different cellular functions.
Because PTEN is a powerful tumor suppressor that nega-
tively regulates phosphatidylinositol 3-kinase/AKT signaling
by dephosphorylating phosphatidylinositol 3,4,5-trisphosphate
(Song et al., 2012), Nedd4-1 was thus described as an oncopro-
tein (Wang et al., 2007). However, a later study using cells
derived from Nedd4-1 knockout mice embryos indicated that
PTEN was not regulated by Nedd4-1 in primary cells (FouladkouCell Reports 7, 871–882, May 8, 2014 ª2014 The Authors 871
Figure 1. Nedd4-1 Interacts with Ras
Proteins
(A) K-Ras associates with Nedd4-1. Halo-tagged
Nedd4-1 C867A (Halo/Nedd4-1 C867A) or Halo-
tag control transiently expressed in HEK293T
cells was purified and applied to SDS-PAGE. The
proteins were visualized by silver staining, and
indicated spots were analyzed by mass spec-
trometry.
(B) Interaction of endogenous Nedd4-1 and Ras
proteins. Cell lysates from HEK293T were sub-
jected to IP with specific antibodies to K-Ras,
H-Ras, or N-Ras followed by immunoblotting (IB)
to detect endogenous Nedd4-1.
(C) In vitro interaction between Nedd4-1 and
Ras proteins. Bacterially expressed and purified
FLAG-tagged K-Ras (F/K-Ras), H-Ras (F/H-Ras),
or N-Ras (F/N-Ras) and GST-tagged Nedd4-1
(GST/Nedd4-1) were subjected to GST pull-down
assays as indicated. Associated Ras proteins
were detected with anti-FLAG. GST and GST/
Nedd4-1 were determined by Ponceau S staining.
(D) Nedd4-1 colocalizes with Ras proteins at
plasmamembrane. HeLa cells were cotransfected
with different FLAG-tagged Ras and HA-tagged
Nedd4-1 C867A (HA/Nedd4-1 C867A) as indi-
cated. Localization of Ras (red) and Nedd4-1
(green) was detected by immunofluorescence.
The nuclei were stained with DAPI (blue). The scale
bars indicate 5 mm.et al., 2008). Interestingly, it was found that phosphorylation of
PTEN by tyrosine kinase Rak inhibits the interaction between
Nedd4-1 and PTEN (Yim et al., 2009), suggesting that Nedd4-1
may target PTEN only in certain oncogenic contexts such as
loss of Rak. In this study, we demonstrate that Nedd4-1 plays
a key role in suppressing tumorigenesis, likely by targeting Ras
proteins for degradation in normal cells. Importantly, we show
that oncogenic activation of Ras evades the Nedd4-1-mediated
degradation, leading to an aggravated PTEN degradation by
rendering Nedd4-1 overexpressed in cancer cells, presenting a
root cause for uncontrolled activation of Ras and potential initia-
tion of tumorigenesis.
RESULTS
Nedd4-1 Interacts with Ras Proteins
To systematically identify binding partners for Nedd4-1, we
carried out affinity purification using human embryonic kidney
293T (HEK293T) cells by the HaloTag system (Promega), fol-
lowed by mass spectrometry analysis to determine the identities872 Cell Reports 7, 871–882, May 8, 2014 ª2014 The Authorsof Nedd4-1 binding proteins. Among the
detected proteins, the small GTPase
K-Raswas identified (Figure 1A). To verify
the interaction, we used specific anti-
bodies to immunoprecipitate endoge-
nous K-Ras, H-Ras, or N-Ras from
HEK293T cell lysate, and ascertained
that endogenous Nedd4-1 was indeed
coprecipitated with all three major formsof Ras proteins (Figure 1B), suggesting that Nedd4-1 and Ras
proteins interact endogenously.
Next, we performed in vitro GST pull-down assay to examine
whether Nedd4-1 and Ras could directly interact. Using bacteri-
ally produced FLAG-tagged Ras proteins to incubate with GST
or GST/Nedd4-1 beads, we found that GST/Nedd4-1 could
pull down all three forms of Ras proteins, indicating a direct inter-
action between Nedd4-1 and Ras proteins (Figure 1C). Further-
more, we determined that Nedd4-1 and Ras proteins were
mainly colocalized at plasma membrane using immunofluores-
cence assay (Figure 1D).
Nedd4-1 Targets Ras Proteins for Ubiquitination and
Degradation
Because Nedd4-1 is an E3 ubiquitin ligase, we asked whether
Ras proteins are substrates for Nedd4-1. We first examined
effects of Nedd4-1 overexpression on steady-state levels of
Ras proteins. Indeed, wild-type (WT) Nedd4-1, but not catalyti-
cally inactive mutant Nedd4-1 C867A or its closest family mem-
ber Nedd4-2, significantly decreased both the endogenous and
Figure 2. Nedd4-1 Targets Ras Proteins for
Ubiquitination and Degradation
(A) Nedd4-1 overexpression decreases endoge-
nous levels of Ras proteins. HEK293T cells
were transiently transfected with FLAG-tagged
Nedd4-1 (F/Nedd4-1) or Nedd4-2 (F/Nedd4-2),
WT or catalytically inactive mutants C867A or
C942A as indicated. Total cell lysates were sub-
jected to immunoblotting to determine the protein
levels. Levels of GAPDH were used as a loading
control.
(B) Knocking down Nedd4-1 increases endoge-
nous Ras protein levels. HEK293T cells were
transfected with control shRNA (sh-con) or
Nedd4-1 shRNA (sh-N4-1-A or sh-N4-1-B), and
the endogenous protein levels of Ras and
Nedd4-1 were detected by immunoblotting.
(C) Nedd4-1 promotes ubiquitination of K-Ras.
After overnight treatment of 120 mM chloroquine,
HEK293T cells transfected with indicated combi-
nations of F/K-Ras, Myc-tagged Nedd4-1 (Myc/
Nedd4-1) (WT or C867A), and HA-tagged ubiquitin
(HA/Ub) were subjected to anti-FLAG IP, eluted
by boiling in 1% SDS, and then reprecipitated
with anti-FLAG (23 IP). The ubiquitin-conjugated
K-Ras ((Ub)n-K-Ras) was detected with anti-HA.
(D) Direct ubiquitination of K-Ras mediated by
Nedd4-1 in vitro. GST/Nedd4-1 (WT or C867A)
and F/K-Ras purified from bacteria were sub-
jected to an in vitro ubiquitination assay. Ubiq-
uitinated F/K-Ras was detected with anti-Ub.
(E) Nedd4-1 regulates turnover rates of K-Ras.
HEK293T cells were transfected with combina-
tions of F/K-Ras, F/Nedd4-1, control shRNA,
and Nedd4-1 shRNA as indicated. The levels of
F/K-Ras at different time points after cyclohexi-
mide (CHX) treatment were determined by immu-
noblotting the total cell lysates and quantification
using Image Lab software (Bio-Rad) with GAPDH
as a loading control. Results plotted are the
amounts of F/K-Ras at each time point relative to
the level at time 0.exogenous Ras protein levels (Figures 2A and S1A–S1C), sug-
gesting a specific role of Nedd4-1 in downregulation of Ras
protein levels. Accordingly, knocking down Nedd4-1 markedly
increased endogenous Ras protein levels (Figures 2B and
S1D). In addition, the lysosome inhibitor chloroquine, but not
the proteasome inhibitor MG-132, could reverse the decrease
of Rasmediated by Nedd4-1, indicating that this downregulation
of Ras is likely through the lysosome pathway (Figures S1E and
S1F). Furthermore, the effect of Nedd4-1 on downregulating
total Ras protein levels was verified in various other cell lines
including human cervical cancer HeLa cells, human gastric can-
cer BGC-823 cells, mouse fibroblast NIH 3T3 cells, and mouse
embryonic fibroblast (MEF) cells (Figures S1G–S1J).
Next, we examined whether Nedd4-1 could regulate ubiqui-
tination of Ras proteins. As predicted, overexpression of
WT Nedd4-1 but not Nedd4-1 C867A mutant markedly
enhanced ubiquitination of all three forms of Ras (Figures 2Cand S1K). We also used bacterially expressed FLAG-tagged
Ras proteins and GST/Nedd4-1 to perform in vitro ubiquitina-
tion assay and found that Nedd4-1 could directly catalyze
ubiquitin conjugation of Ras proteins (Figures 2D and S1L),
confirming that Ras proteins are direct substrates of
Nedd4-1. Accordingly, coexpression of Nedd4-1 significantly
decreased the half-lives of Ras proteins, whereas knockdown
of Nedd4-1 prolonged the half-lives of Ras proteins (Figures
2E, S1M, and S1N).
Knockdown of Nedd4-1 Induces Cell Transformation
and Tumorigenesis
Because Ras small GTPases are well-known proto-oncopro-
teins, we hypothesized that Nedd4-1 might be involved in con-
trolling tumorigenesis. To test this hypothesis, we first performed
soft agar colony-formation assays to examine whether knock-
down of Nedd4-1 could induce cell transformation. We usedCell Reports 7, 871–882, May 8, 2014 ª2014 The Authors 873
Figure 3. Nedd4-1 Suppresses Tumorigen-
esis by Targeting Ras
(A) Knockdown of Nedd4-1 induces trans-
formation of NIH 3T3 cells. NIH 3T3 cells trans-
duced with lentivirus encoding control shRNA or
Nedd4-1 shRNA (sh-N4-1-A or sh-N4-1-B) were
subjected to soft agar assay. The scale bars
indicate 100 mm. Viable colonies formed were
quantitated and plotted as mean ± SD of six in-
dependent experiments.
(B) Simultaneously silencing Ras inhibits Nedd4-1
knockdown-induced transformation of NIH 3T3
cells. NIH 3T3 cells transduced with indicated
combinations of lentivirus encoding Nedd4-1
shRNA and Ras shRNA were applied to soft agar
assay. Viable colonies formed were quantitated
and plotted as mean ± SD of three independent
experiments.
(C and D) Knockdown of Nedd4-1 induces
tumorigenicity of NIH 3T3 cells in nudemice. Nude
mice were subcutaneously injected with NIH 3T3
cells stably expressing control shRNA (left flank) or
Nedd4-1 shRNA (right flank) to observe tumor
development (C), and volumes of tumor were
determined and plotted as mean ± SD of six in-
dependent experiments (D).
(E) Nedd4-1 and K-Ras present inverse correla-
tions in some human colon cancer specimens.
Protein levels of Nedd4-1 and K-Ras were deter-
mined by immunoblotting the protein extracts
from tumor tissues (T) and their matched sur-
rounding normal mucosal tissues (N). GAPDH was
used as a loading control.
(F) Increase of K-Ras is not due to upregulation of
its transcription. The mRNA levels of K-Ras in
tumor (T) and matching normal tissues (N) were
measured by real-time quantitative PCR using
GAPDH as an internal control. Data are presented
as mean ± SD of three independent experiments.
(G) The protein levels of Nedd4-1 and K-Ras in
colorectal carcinomas. The protein levels of
Nedd4-1 (blue line) andK-Ras (red line) observed in
aseriesof 46colorectal carcinomaswereplotted in
the order of increasing Nedd4-1 protein levels.
(H) Correlation between Nedd4-1 and K-Ras
protein levels in colorectal cancer. A total of 46
samples of human colorectal cancer were classi-
fied into 2 groups based on the protein levels of
Nedd4-1 in tumor tissues compared to sur-
rounding normal tissues (low Nedd4-1, 22 sam-
ples; high Nedd4-1, 24 samples). The correlation
coefficient r value was obtained by Spearman’s
rank correlation analysis.two independent small hairpin RNAs (shRNAs) (sh-N4-1-A and
sh-N4-1-B) targeting different regions of Nedd4-1 mRNA to
knock down Nedd4-1 in NIH 3T3 cells, and then seeded the cells
in soft agar. Strikingly, knockdown of Nedd4-1 dramatically
induced colony formation of NIH 3T3 cells in soft agar (Figure 3A),
revealing a role of Nedd4-1 in suppressing cell transformation.
To assess whether Nedd4-1 knockdown-induced cell transfor-
mation is through upregulating Ras proteins, we knocked
down both Ras and Nedd4-1. As shown in Figure 3B, simulta-
neous knockdown of Ras strongly suppressed Nedd4-1 knock-
down-induced transformation of NIH 3T3 cells, confirming that874 Cell Reports 7, 871–882, May 8, 2014 ª2014 The Authorsthe transformation induced by Nedd4-1 knockdown is depen-
dent on Ras.
Next, we tested the in vivo tumor-forming capacity of NIH 3T3
cells with Nedd4-1 knocked down. To this end, we generated
multiple NIH 3T3 clonal lines stably expressing sh-N4-1-A or
sh-N4-1-B, and injected subcutaneously into athymic nude
mice to inspect the tumor formation. Strikingly, both sh-N4-1-A
and sh-N4-1-B-expressing cells formed large tumors within
1 month in nude mice, whereas NIH 3T3 cells with control
shRNA did not (Figure 3C). The growth rates of the tumors
were measured and plotted in Figure 3D. Thus, our results
Figure 4. Ras Evades Nedd4-1-Mediated
Degradation via Site Mutation or Consecu-
tive Activation
(A) G12V mutation restrains Nedd4-1-mediated
K-Ras degradation. HEK293T cells transfected
with F/K-Ras (WT or V12) and F/Nedd4-1 (WT or
C867A) as indicated were subjected to immuno-
blotting.
(B) Nedd4-1 overexpression decreases levels of
WT K-Ras but not V12 mutant. Endogenous levels
of WT or V12 K-Ras in HT-29 or SW480 cells
overexpressing F/Nedd4-1 (WT or C867A) were
examined by immunoblotting.
(C) Knocking down Nedd4-1 increases endoge-
nous levels of WT K-Ras but not V12 mutant. HT-
29 cells or SW480 cells were transduced with
lentivirus encoding control shRNA or Nedd4-1
shRNA, and endogenous levels of WT K-Ras in
HT-29 cells and V12 mutant in SW480 cells were
examined by immunoblotting.
(D) EGF treatment inhibits Nedd4-1-mediated
Ras degradation. HEK293T cells overexpressing
F/Nedd4-1 (WT or C867A) were treated with or
without EGF (50 ng/ml) for the indicated time and
then subjected to immunoblotting.
(E) Overexpression of EGFR prevents Nedd4-1-
mediated Ras degradation. Endogenous protein
levels of total Ras in HEK293T cells transduced
with indicated combinations of lentivirus encoding
WT or constitutive active form (L813R) C-terminal
HA-tagged EGFR (EGFR/HA) and F/Nedd4-1 (WT or C867A) were determined by immunoblotting the total cell lysates.
(F) EGF signaling-caused increase of Ras levels is not through upregulating Ras transcription. The mRNA levels of K-Ras, H-Ras, and N-Ras in HEK293T cells
treated with or without EGF (50 ng/ml) for the indicated hours, or transfected with WT or L813R EGFR, were measured by real-time RT-PCR using GAPDH as an
internal control. Data are presented as mean ± SD of three independent experiments.clearly show that Nedd4-1 has a critical role in suppressing
tumorigenesis.
To explore whether there is any correlation between Nedd4-1-
mediated Ras degradation and human tumorigenesis, we
analyzed specimens from 46 patients with colorectal cancer.
We found that in four tumor samples, levels of Nedd4-1 proteins
were decreased, whereas protein levels of K-Ras were in-
creased in the tumor tissues compared with surrounding normal
mucosal tissues (Figure 3E; Table S1), and the increase of K-Ras
protein was not due to upregulation of K-Ras mRNA levels (Fig-
ure 3F). Intriguingly, the overall relationship between Nedd4-1
protein levels and K-Ras protein levels was not reversely corre-
lated (Figure 3G), and in about 30% of tumor samples (14 out
of 46), the levels of Nedd4-1 protein were upregulated and the
Ras protein levels were not decreased (Figure 3H). We thus
decided to pursue the underlying mechanism for this apparently
conflicting phenomenon.
Oncogenic Activation of Ras Blocks Nedd4-1-Mediated
Ras Degradation
Because oncogenic mutations of Ras occur frequently in human
cancers (Pylayeva-Gupta et al., 2011), we wondered whether
these mutations could inhibit Nedd4-1-mediated Ras degrada-
tion. To test this possibility, we examined the ability of
Nedd4-1 to mediate degradation of various Ras mutants that
commonly exist in cancer cells. Remarkably, many Ras muta-
tions, especially on Gly12, significantly attenuated Nedd4-1-mediated Ras degradation (Figures 4A, S2A, and S2B). This
was further confirmed by examining the endogenous levels
of K-Ras G12V (V12) mutant that is harbored in the colon
cancer cell line SW480. Overexpression of Nedd4-1 markedly
decreased WT K-Ras in the colon cancer cell HT-29, whereas
it had no effect on the steady-state levels of K-Ras V12 in
SW480 (Figures 4B and S2C). Meanwhile, knockdown of
Nedd4-1 increased levels of WT K-Ras protein in HT-29 but
did not affect K-Ras V12 protein levels in SW480 (Figures 4C
and S2D).
Ras small GTPases are physiologically activated by receptor
tyrosine kinases such as EGFR, and overexpression of EGFR
or dominant-active mutations of EGFR are frequently found in
tumors (Downward, 2003). Therefore, we further tested whether
EGF signaling could protect Ras proteins from Nedd4-1-medi-
ated degradation. Indeed, treatment of EGF or overexpressing
WT EGFR or dominant-active mutant EGFR L813R effectively
rescued Ras from Nedd4-1-mediated degradation (Figures 4D,
4E, S2E, and S2F). Of note, treatment of EGF or overexpressing
EGFRs did not upregulate mRNA levels of Ras (Figure 4F), indi-
cating that EGF signaling is through inhibiting Nedd4-1-medi-
ated Ras degradation to protect Ras.
Binding of GTP Attenuates Ubiquitination of Ras
Mediated by Nedd4-1
To investigate the mechanism by which activation of Ras
helps Ras proteins circumvent the control of Nedd4-1, we firstCell Reports 7, 871–882, May 8, 2014 ª2014 The Authors 875
Figure 5. Oncogenic Mutation or Constant
Activation Protects K-Ras by Attenuating
Nedd4-1-Mediated Ubiquitination
(A) G12V mutation or EGF treatment does not
inhibit binding of K-Ras to Nedd4-1. HEK293T
cells transfected with F/K-Ras (WT or V12) and
HA/Nedd4-1 C867A as indicated were treated
with or without EGF (50 ng/ml for 24 hr) as indi-
cated before being subjected to coimmunopreci-
pitation assay.
(B) Nedd4-1 interacts with both GDP- and GTPgS-
bound forms of K-Ras in vitro. Nucleotide-free
F/K-Ras obtained by EDTA treatment was loaded
with GDP or GTPgS and then subjected to GST
pull-down assay as indicated. GST and GST/
Nedd4-1 were detected by Ponceau S staining.
(C) G12V mutation attenuates Nedd4-1-mediated
K-Ras ubiquitination. HEK293T cells transfected
with indicated combinations of F/K-Ras (WT or
V12), Myc/Nedd4-1 (WT or C867A), and HA/Ub
were subjected to ubiquitination assay.
(D) EGF treatment attenuates Nedd4-1-mediated
K-Ras ubiquitination. HEK293T cells transfected
with indicated combinations of F/K-Ras, Myc/
Nedd4-1 (WT or C867A), and HA/Ub were treated
with or without EGF (50 ng/ml) for 24 hr and then
subjected to ubiquitination assay.
(E) Overexpression of EGFR diminishes Nedd4-1-
mediated K-Ras ubiquitination. HEK293T cells
transfected with indicated combinations of F/K-
Ras, Myc/Nedd4-1 (WT or C867A), EGFR/HA
(WT or L813R), and HA/Ub were subjected to
ubiquitination assay.
(F) Load of GTPgS inhibits Nedd4-1-mediated
K-Ras ubiquitination. Nucleotide-free F/K-Ras
was loaded with GDP or GTPgS and then sub-
jected to in vitro ubiquitination assay as indicated.hypothesized that the interaction between Nedd4-1 and Ras
might be disturbed by Ras mutation or EGF treatment. To our
surprise, G12V mutation or EGF treatment did not block binding
of K-Ras to Nedd4-1. As shown in Figure 5A, Nedd4-1 C867A
displayed an equal binding ability to both WT and V12 K-Ras in
cells, and GST/Nedd4-1 evenly interacted with GDP-bound,
GTPgS-bound, and guanine-free forms of K-Ras in vitro (Fig-
ure 5B), suggesting that activation of Ras does not affect its
binding affinity to Nedd4-1.
We then examined the effect of G12V mutation and EGF
signaling on Nedd4-1-regulated ubiquitination of K-Ras. Indeed,
the ubiquitination of K-Ras catalyzed by Nedd4-1 was signifi-
cantly diminished by G12Vmutation (Figure 5C) or EGF signaling
(Figures 5D and 5E). Meanwhile, loading of GTPgS on K-Ras or
G12V mutation markedly inhibited Nedd4-1-catalyzed K-Ras
ubiquitin conjugation in vitro (Figures 5F and S3A). We further
identified Lys5 as the ubiquitination site in K-Ras using muta-
tional analysis (Figures S3B–S3D). Interestingly, the side chain
of Lys5 goes through a significant conformational change876 Cell Reports 7, 871–882, May 8, 2014 ª2014 The Authorswhen Ras undergoes interchanging be-
tween GDP- and GTP-bound states (Fig-
ures S3E–S3H), suggesting that binding
of GTP might interrupt the access ofubiquitin to Lys5. Hence, our results indicated that aberrant acti-
vation of Ras, as a result of oncogenic mutations of Ras or
persistent activation of EGFR, enables tumor cells to overcome
Nedd4-1-mediated inhibition of Ras signaling by circumventing
Nedd4-1-regulated Ras ubiquitination.
Ras Signaling Upregulates Transcription of Nedd4-1
Because we observed that in some tumor specimens both
Nedd4-1 protein levels and K-Ras protein levels were upregu-
lated (Figure 3H), we further examined the role of Ras signaling
in regulation of Nedd4-1. Remarkably, overexpressing K-Ras
(WT or V12) or treatment of EGF significantly increased endoge-
nous levels of Nedd4-1 in HEK293T cells (Figures 6A, 6B, S4A,
and S4B), suggesting that Ras signaling may upregulate
Nedd4-1 levels. We examined the mRNA levels of Nedd4-1 in
various typesof cells byquantitativeRT-PCRand found thatover-
expressing Ras or treatment of EGF markedly enhanced tran-
scription of Nedd4-1 (Figures 6C and 6D), indicating a negative
feedback regulatory loop between Nedd4-1 and Ras signaling.
We reinforced the role of Ras signaling in regulating Nedd4-1
transcription by analyzing published mRNA microarray data
through the publicly available database Oncomine (http://www.
oncomine.com). Based on the data of mRNA levels retrieved
from a subset database containing expression profiles of 56
colorectal cancer samples (Figure S4C), we found that there
were good positive correlations between K-Ras and Nedd4-1
(r = 0.82; p < 0.001) (Figures 6E and 6F) and between EGFR
andNedd4-1 (r = 0.84; p < 0.001) (Figures 6G and 6H). Moreover,
we detected activated EGFR levels using a phosphotyrosine-
specific antibody (anti-pY1068-EGFR) and confirmed that the
protein levels of Nedd4-1 were increased when levels of phos-
phorylated EGFRwere upregulated in tumor samples by western
blot (Figure 6I; Table S1) and immunohistochemistry assays
(Figure 6J).
Ras Oversignaling Promotes PTEN Degradation via
Nedd4-1
Given the fact that Nedd4-1 levels were upregulated in a large
percentage of tumor samples (Figure 3H), which suggests that
cancer cells may take advantage of Nedd4-1 to promote tumor
progression when Ras proteins overcome the control of
Nedd4-1, we next decided to explore the underlying role of
Ras signaling-enhanced transcription of Nedd4-1 in cancer
cells. Because a previous study reported that Nedd4-1 could
target tumor suppressor PTEN for degradation (Wang et al.,
2007), which plays an important role in promoting tumor devel-
opment, we therefore examined whether Ras activation had
any effect on protein levels of PTEN. Indeed, while the
Nedd4-1 levels were increased upon K-Ras overexpression or
EGF treatment, the PTEN levels were significantly decreased in
various types of cancer cells including HeLa, HT-29, BGC-823,
and HepG2 (Figures 7A, 7B, and S5A–S5F), suggesting that
Ras signaling may promote PTEN degradation through upregu-
lating Nedd4-1 levels in cancer cells. Moreover, expression of
exogenous Nedd4-1 decreased endogenous PTEN levels (Fig-
ures 7C and S5G), whereas knockdown of Nedd4-1 resulted in
an increase of PTEN levels (Figures 7D and S5H). Consistently,
knockdown of Nedd4-1 in SW480 upregulated the PTEN levels
but did not affect the endogenous K-Ras V12 levels (Figures
S5I and S5J), and significantly impaired the colony formation
of SW480 in soft agar (Figure S5K).
To confirm that the decrease of PTEN caused by hyperactive
Ras signaling is through Nedd4-1, we first examined whether
Ras activation could affect transcription of PTEN. As shown in
Figure 7E, the mRNA levels of PTEN were not significantly
changed in response to Ras overexpression or EGF treatment,
indicating that Ras signaling-induced decrease of PTEN was
not due to downregulating PTEN transcription. We next knocked
down Nedd4-1 and tested whether PTEN levels could still be
decreased by activation of Ras. Indeed, Ras overexpression or
EGF treatment failed to downregulate PTEN when Nedd4-1
was knocked down, confirming that the decrease of PTEN by
Ras signaling was dependent on Nedd4-1 (Figures 7F, 7G,
S5L, and S5M).
To validate the correlation between Ras oversignaling and
PTEN levels in human cancers, we examined the PTEN levels
in human colorectal cancer samples. Significantly, PTEN levelswere decreased in about 80% (12 out of 14) of the tumor samples
with high Ras and Nedd4-1 levels (Figure 7H; Table S1), and the
overall relationship betweenprotein levels of Ras andPTEN in the
46 colorectal tumor samples was reversely correlated (r =0.62)
(Figure 7I), suggesting a malignant role of Ras oversignaling in
downregulating PTEN through stimulating Nedd4-1 expression.
Furthermore, we confirmed that Ras-induced downregulation
of PTEN was not through affecting PTEN mRNA levels, by
analyzing mRNA microarray data through Oncomine (Figures
S5N and S5O). Thus, our study demonstrated a fine-tuned
interplay between Nedd4-1, Ras and PTEN. Constitutive activa-
tion of Ras by oncogenic mutations or growth factors impedes
Nedd4-1-mediated Ras degradation, in turn causes Nedd4-1
overly expressed to target PTEN for degradation, thereby switch-
ing Nedd4-1 to an oncoprotein, leading to tumor progression.
DISCUSSION
Mechanistic studies for controlling Ras activity have beenmainly
focused on the regulation of cycling between GDP-bound and
GTP-bound forms of Ras proteins regulated by GEFs and
GAPs, and the membrane association mediated by posttransla-
tional modification such as farnesylation and palmitoylation at
the carboxy-terminal CAAX motif (Ahearn et al., 2012). Emerging
evidence suggested that ubiquitination of Ras plays important
roles in regulating Ras stability and activity as well (Pfleger,
2011). Recent studies showed that mono- or diubiquitination
restricted activities of H-Ras and N-Ras (Colicelli, 2010; Xu
et al., 2010; Yan et al., 2009, 2010), whereasmono-ubiquitination
of K-Ras promoted its activity (Sasaki et al., 2011). It has been
reported that H-Ras can also be targeted for polyubiquitination
and degradation by b-TrCP (Kim et al., 2009), and aberrant acti-
vation of Wnt/b-catenin signaling promotes intestinal tumorigen-
esis by stabilizing H-Ras (Jeong et al., 2012). However, it remains
unclear whether it has to be distinct ubiquitin ligases for different
Ras proteins, or one same ubiquitin ligase can target all three
forms of Ras, and what roles of Ras ubiquitination would exert
in tumorigenesis (Pfleger, 2011).
Our current study demonstrates Nedd4-1 as a general E3
ubiquitin ligase for controlling the abundance of all the three
major forms of Ras, revealing a fundamental role of Nedd4-1 in
regulating Ras signaling. Importantly, the interplay between
Ras signaling-regulated transcription of Nedd4-1 and Nedd4-
1-mediated Ras degradation comprises a negative feedback
regulatory loop. We found that a near-complete knockdown
of Nedd4-1 caused cell senescence and that raising Ras to
a moderately increased level by restrained knockdown of
Nedd4-1 promotes cell growth and transformation. These obser-
vations are in good agreement with previous reports that low
levels activation of Ras promoted cell proliferation, whereas
high levels activation of Ras caused oncogene-induced senes-
cence (OIS) (DeNicola and Tuveson, 2009; Sarkisian et al.,
2007; Serrano et al., 1997). Hence, the feedback regulatory
loop between Ras and Nedd4-1 is critical for finely adjusting
Ras signaling, which might be essential for maintaining homeo-
stasis of cell growth and senescence. Interruption of this regula-
tory loop may result in dysregulation of Ras signaling and
tumorigenesis.Cell Reports 7, 871–882, May 8, 2014 ª2014 The Authors 877
Figure 6. Ras Activation Upregulates Nedd4-1 Transcription
(A) Overexpressing Ras increases endogenous Nedd4-1 levels. Nedd4-1 levels in HEK293T cells transfected with F/K-Ras (WT or V12) were examined by
immunoblotting.
(B) Treatment of EGF increases endogenous levels of Nedd4-1. HEK293T cells were treatedwith different doses of EGF as indicated for 36 hr before being applied
to western blot to determine the endogenous levels of Nedd4-1.
(C) Ras overexpression enhances Nedd4-1 transcription. The mRNA levels of Nedd4-1 in HEK293T, HeLa, BGC-823, or HT-29 cells transfected with K-Ras (WT
or V12) were measured by real-time RT-PCR using GAPDH as an internal control. Data are presented as mean ± SD of three independent experiments.
(D) EGF treatment upregulates Nedd4-1 transcription. The mRNA levels of Nedd4-1 in HEK293T, HeLa, BGC-823, or HT-29 cells treated 2 hr with different doses
of EGF as indicated were measured by real-time quantitative PCR using GAPDH as an internal control. Data are presented as mean ± SD of three independent
experiments.
(legend continued on next page)
878 Cell Reports 7, 871–882, May 8, 2014 ª2014 The Authors
We have also found that activated Ras proteins, as a result of
either activating mutations or EGF signaling, are resistant to
Nedd4-1-mediated degradation. Aberrant activation of Ras is a
common prelude to tumorigenesis, which is associated with
about 30% of all human cancers. Constitutively active Ras
mutants constantly activate downstream signaling pathways,
thereby acting as a major etiological factor for cancer develop-
ment. Apparently, our study provides a fundamental mechanism
by which oncogenic activation of Ras is such a prevalent cause
for tumor development. It would be necessary for normal cells to
temporarily relieve Nedd4-1-mediated Ras degradation in
response to upstream growth signaling such as EGF; however,
activating mutations of Ras or persistent stimulation of EGF
signaling will utterly block Nedd4-1-mediated Ras degradation,
therefore enabling Ras proteins to escape the control of
Nedd4-1, which might be essential for Ras-driven tumorigen-
esis. Moreover, what is worse is that the uncontrolled Ras
signaling noxiously upregulates Nedd4-1 levels to enhance
Nedd4-1-mediated PTEN degradation in cancer cells, thus pro-
moting malignancy of cancer cells. It is worthwhile to point out
that the Nedd4-1-mediated PTEN degradation might primarily
happen in cancer cells under certain oncogenic circumstances
because previous studies showed that Nedd4-1was not respon-
sible for regulation of PTEN in primary cells (Cao et al., 2008;
Fouladkou et al., 2008), and tyrosine kinase Rak acted as a tumor
suppressor by inhibiting Nedd4-1-regulated PTEN degradation
(Yim et al., 2009).
It is widely accepted that cancer cells can take advantage of
genes or signaling pathways that are needed for the autonomy
of cellular proliferation involved in normal growth or tissue
renewal (Condeelis et al., 2005). We present here another
example for this concept that cancer cells hijack the E3 ubiquitin
ligase Nedd4-1, switch it to a proto-oncoprotein, and thereby
promote the tumor progression. Hence, we have to reshape
the strategy for cancer therapy using Nedd4-1 as a molecular
target. It would be necessary to further dissect the mechanisms
for the two opposite roles of Nedd4-1 in tumorigenesis in order to
specifically block Nedd4-1-mediated PTEN degradation while
retaining its activity toward Ras proteins.
EXPERIMENTAL PROCEDURES
Antibodies and Chemical Reagents
The mouse anti-K-Ras monoclonal (ab16795), rabbit anti-H-Ras monoclonal
(ab16881), goat anti-N-Ras polyclonal (ab77392), and mouse anti-Ras (for(E) The mRNA levels of K-Ras and Nedd4-1 in colorectal carcinomas. The mRN
colorectal carcinomas were plotted in the order of increasing K-Ras expression
oncomine.com).
(F) Positive correlation between mRNA levels of K-Ras and Nedd4-1. The correlat
tissues was analyzed by Pearson’s correlation analysis with a coefficient of 0.82
(G) The mRNA levels of EGFR and Nedd4-1 in colorectal carcinomas. Same as i
(H) Positive correlation between mRNA levels of EGFR and Nedd4-1. Same as in
correlation coefficient (r) was 0.84 (p < 0.001).
(I) Positive correlation between protein levels of Nedd4-1 and phospho-EGFR in
(pY1068) were determined by immunoblotting the protein extracts from tumor tiss
used as a loading control.
(J) Positive correlation between expression of Nedd4-1 and phospho-EGFR in co
normal mucosal tissue (N) in typical colorectal tumor samples with (bottom) or w
nohistochemistry assay. The scale bars indicate 200 mm.total Ras proteins) monoclonal (ab55391) antibodies were from Abcam; rabbit
anti-Nedd4-1 polyclonal antibody (07-049) was from Millipore; mouse anti-
FLAG M2 antibody (F1804) was from Sigma-Aldrich; rat anti-HA monoclonal
antibody (11867431001) was from Roche; mouse anti-Myc (SC-40), anti-Ub
(SC-8017), and anti-glyceraldehyde 3-phosphate dehydrogenase (GAPDH;
SC-61) monoclonal antibodies were from Santa Cruz Biotechnology; and rab-
bit anti-pEGFR (Tyr1068) (phospho-EGFR) (3777) and rabbit anti-PTEN mono-
clonal (9188) antibodies were from Cell Signaling Technology. The chemical
reagents chloroquine, cycloheximide, EGF, GTPgS, and GDP were from
Sigma-Aldrich; MG-132 was from Boston Biochem.
DNA Constructs
Human Nedd4-1 andNedd4-2 were generous gifts fromDr. W. Sundquist, and
human EGFR was a kind gift from Dr. J. Han. Different tagged Nedd4-1 and
FLAG-Nedd4-2 were generated by subcloning PCR products of Nedd4-1
and Nedd4-2 into pCMV5 vector. The catalytic inactive mutants of Nedd4-1
C867A and Nedd4-2 C942A and constitutive active mutant EGFR-L813R
were generated by PCR-based site-directed mutagenesis according to previ-
ous reports byChung et al. (2008), Hamilton et al. (2001), and Paez et al. (2004).
K-Ras, H-Ras, and N-Ras were cloned from HEK293T cells using RT-PCR,
and various mutations of Ras were introduced by PCR-based site-directed
mutagenesis. Nedd4-1 and Ras were subcloned into pGEX4T-1 vector for
bacterial expression. For gene silencing, shRNAs were all generated by using
pLL3.7 vector (Addgene; Table S2).
Cell Culture, Transfection, Lentivirus Infection, and Stable Cell Line
Generation
Mouse fibroblast NIH 3T3, MEF, HEK293T, human cervical cancer HeLa, and
human hepatocellular carcinoma HepG2 cells were grown in high-glucose
Dulbecco’s modified Eagle’s medium (Invitrogen), human colon cancer
SW480 cells and human gastric cancer BGC-823 cells were grown in RPMI-
1640 medium (Invitrogen), and human colon cancer HT-29 cells were grown
in McCoy’s 5A medium (Sigma-Aldrich), all supplemented with 10% (v/v) fetal
bovine serum (Gibco) and 100 U/ml streptomycin and penicillin (Millipore), at
37C in a humidified 5% CO2 incubator. HEK293T, NIH 3T3, SW480,
HepG2, and HeLa cells were obtained from ATCC. HT-29 and BGC-823 cells
were purchased from the Cell Bank of the Chinese Academy of Sciences
(Shanghai). MEF cells prepared from embryos of mice and immortalized using
large T antigen were a kind gift from Dr. J Han.
HEK293T cells were transiently transfected using the calcium phosphate
methods as previously described (Wang et al., 2006). HeLa, SW480, HepG2,
and BGC-823 cells were transfected with Lipofectamin 2000 (Invitrogen) or
electroporation (Bio-Rad). Recombinant lentivirus used to infect NIH 3T3,
MEF, and HT-29 cells for shRNA or protein expression was generated by the
ViraPower Lentiviral Expression System (Invitrogen) according to the manu-
facturer’s instruction.
To generate Nedd4-1 shRNA stably expressing cells, NIH 3T3 cells were
transduced with lentivirus encoding neomycin-resistance gene and control
shRNA or Nedd4-1 shRNA. Neomycin-resistant colonies were then screened
by immunoblotting to examine Nedd4-1 expression level with anti-Nedd4-1
antibody.A levels of K-Ras (blue line) and Nedd4-1 (red line) observed in a series of 56
. The mRNA data were obtained from the Oncomine database (http://www.
ion between Nedd4-1 and K-Ras mRNA expression in 56 human colon cancer
(p < 0.001).
n (E), except that mRNA levels of EGFR instead of K-Ras were used.
(F), except that mRNA levels of EGFR instead of K-Ras were used. Pearson’s
colorectal tumor samples. The protein levels of Nedd4-1 and phospho-EGFR
ues (T) and their matched surrounding normal mucosal tissues (N). GAPDHwas
lorectal cancer. The expression of Nedd4-1 in tumor tissue (T) and surrounding
ithout (top) upregulation of phospho-EGFR (pY1068) was detected by immu-
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Figure 7. Ras Oversignaling Promotes PTEN Degradation through Upregulating Nedd4-1
(A) Overexpression of K-Ras decreases PTEN levels. Endogenous levels of Nedd4-1 and PTEN in HeLa cells overexpressing F/K-Ras (WT or V12) were examined
by immunoblotting.
(B) EGF treatment decreases PTEN levels in HeLa cells. HeLa cells were treated overnight with or without indicated doses of EGF and then subjected to
western blot.
(C) Overexpressing Nedd4-1 decreases PTEN levels. Endogenous PTEN levels in HeLa cells overexpressing F/Nedd4-1 (WT or C867A) were determined by
immunoblotting.
(D) Knocking downNedd4-1 increases PTEN levels. HeLa cells expressing control or Nedd4-1 shRNAwere subjected to immunoblotting to determine the protein
levels.
(E) Activation of Ras signaling does not affect PTEN transcription. The mRNA levels of PTEN in HeLa cells transduced with lentivirus encoding K-Ras (WT or V12)
or treated with indicated doses of EGF were measured by real-time quantitative PCR using GAPDH as an internal control. Data are presented as mean ± SD of
three independent experiments.
(legend continued on next page)
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Immunoprecipitation, Immunoblotting, GST Pull-Down, and
Ubiquitination Assays
Immunoprecipitation (IP), immunoblotting, GST pull-down, and ubiquitination
assays were performed as previously described (Wang et al., 2006). Briefly,
cell lysates prepared using ice-cold lysis buffer TNTE 0.5% (50 mM Tris-HCl
[pH 7.5], 150 mM NaCl, 1 mM EDTA, and 0.5% Triton X-100, containing
10 mg/ml pepstatin A, 10 mg/ml leupeptin, and 1 mM PMSF) were applied to
IP or immunoblotting assays with appropriate antibodies. For ubiquitination
assay in cells, cell lysates were subjected to anti-FLAG IP, eluted by 5 min
boiling in 1% SDS, then diluted ten times in lysis buffer TNTE 0.5% and reim-
munoprecipitated with anti-FLAG (23 IP). The ubiquitin-conjugated proteins
were detected by immunoblotting. For GST pull-down and in vitro ubiquitina-
tion assays, bacterially expressed GST/Nedd4-1 (WT or C867A) was purified
using glutathione Sepharose beads in TNTE 0.5% buffer. GST/FLAG/Ras
fusion proteins were expressed in E. coli and purified in the presence of
Mg2+ (Hall and Self, 1986). Nonfused FLAG/Ras proteins were obtained by
tobacco etch virus protease cleavage, and nucleotide-free state and a GDP-
or GTPgS-bound form of FLAG/K-Ras were generated as previously
described (Wang et al., 2006).
Affinity Purification of Nedd4-1 Binding Proteins
Halo-tagged Nedd4-1 C867A transiently expressed in HEK293T cells was
purified with Magne HaloTag Beads (Promega) in Halo-tag protein purification
buffer (50 mM HEPES [pH 7.5], 150 mM NaCl, 1 mM dithiothreitol, 0.05%
NP-40, and 1 mM phenylmethanesulfonylfluoride) according to the manufac-
turer’s instruction. The bead-bound proteins were eluted by boiling 3 min
with loading buffer and then subjected to SDS-PAGE. The proteins were
detected with silver staining, and specific bands were excised and analyzed
by mass spectrometry.
Immunofluorescence and Immunohistochemistry Assays
HeLa cells transiently transfected with HA-tagged Nedd4-1 C867A and FLAG-
tagged K-Ras, H-Ras, or N-Ras were grown on glass coverslips. Cells were
washed in PBS, fixed with 4% paraformaldehyde, and permeabilized with
0.25% Triton X-100. FLAG-tagged Ras proteins were detected using mouse
anti-FLAG M2 antibody followed by Alexa Fluor 555-conjugated donkey
anti-mouse secondary antibody (Invitrogen), and HA-tagged Nedd4-1 was
stained using rat anti-HA antibody followed by Alexa Fluor 488-conjugated
donkey antibody to rat immunoglobulin G (Invitrogen). Images were acquired
by using a Zeiss LSM 780 laser-scanning confocal microscope and ZEN
2010 software (Carl Zeiss).
For immunohistochemistry assay, paraffin-embedded tissue samples were
sectioned, deparaffinized, and rehydrated. Sections were stained with hema-
toxylin and eosin (H&E) to examine the morphology. For immunohistochemical
staining, the sections were boiled 20 min in sodium citrate/citric acid mixture
(pH 6.0) for antigen retrieval and then pretreated with peroxidase blocking
buffer (Maxim) for 20 min at room temperature. After being blocked with 5%
normal goat serum for 1 hr at room temperature, the slides were incubated
with appropriate primary antibodies overnight at 4C. The UltraSensitive SP
kit (Maxim) was then used to detect the specific primary antibodies.
Cell Transformation Assay
Forty-eight hours after infection, NIH 3T3 or SW480 cells transducedwith lenti-
virus encoding control shRNA or Nedd4-1 shRNA were applied to soft agar
assay to determine the transformation ability. The cells were harvested and(F) Ras overexpression-induced PTEN degradation is dependent on Nedd4-1. H
Nedd4-1 shRNA were subjected to immunoblotting to examine the endogenous
(G) EGF treatment-induced decrease of PTEN is dependent on Nedd4-1. HeLa cel
treated overnight with or without EGF (50 ng/ml) as indicated. The endogenous N
(H) K-Ras and PTEN are reversely correlated in human colorectal cancer sample
K-Ras were determined by immunoblotting the protein extracts from tumor tissu
used as a loading control.
(I) Correlation between protein levels of K-Ras and PTEN. A total of 46 samples o
levels of Nedd4-1 and K-Ras in tumor tissues compared to surrounding normal t
rank correlation analysis.seeded at 1 3 104 per 35 mm culture dish in 1.5 ml of 0.35% (w/v) Noble
agar (Becton Dickinson) with complete medium. The dishes were precoated
with 1.5 ml of 0.6% (w/v) Noble agar, and 0.5 ml of overlay medium was added
after cell plating. The cells were cultured at 37C in a humidified 5% CO2 incu-
bator for 1–3 weeks. The overlay medium was changed every 3 days. Colonies
formed in soft agar were photographed using a Nikon eclipse Ti-U inverted
microscope.
Tumorigenicity Assay in Nude Mice
NIH 3T3 cells stably expressing control shRNA or Nedd4-1 shRNA were used
for the tumorigenicity assays. The cells were harvested at logarithmic growth
phase by trypsinization, washing, and resuspending in PBS. The cells (0.5–13
107 cells in 150 ml PBS) were subcutaneously injected in nude mice, and the
growth of tumors was monitored for 1 month. For each shRNA, six indepen-
dent clonal lines of NIH 3T3 cells were used for the injection. All animals
were housed and handled with protocols approved by Institutional Animal
Care and Use Committee.
Patient Samples
Primary human colorectal tumor samples and corresponding adjacent normal
tissues were obtained in accordancewith research ethics board approval from
Xiamen University and Zhongshan Hospital. Informed consent was obtained
from all patients. Briefly, all the samples taken after surgery were stocked
in liquid nitrogen for further RNA extraction or immunoblotting assay, or
embedded with paraffin for further immunohistochemistry assay.
Quantitative RT-PCR
Total RNAs were extracted from tissues or cells using TRIzol (Invitrogen), and
cDNA was synthesized with ReverTra Ace qPCR RT kit (Toyobo). Real-time
quantitative PCR was performed using SYBR Green PCRMix (Roche) accord-
ing to the manufacturer’s protocol on a Mastercycler EP gradient S RealPlex2
(Eppendorf). The relative changes of gene expression were determined using
the 2-DDCt method and normalized to GAPDH (Table S3).
Statistical Analysis
Data were expressed as mean ± SD of at least triplicate experiments. For
western blot, protein bands were visualized by a Bio-Rad Molecular Imager
ChemiDoc XRS system and analyzed with Image Lab software (Bio-Rad).
The data significance was evaluated using Student’s t test. p < 0.05 was
considered a statistically significant difference (* p < 0.05, ** p < 0.01, and
*** p < 0.001).
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